Interesting info on Ecotality Inc. regarding Swartz and Michael C Kendrick-everyone seems to love the Caymans

http://google.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHTML1?ID=6710673&SessionID=zgW7Hjuc9vn9i77

What a coincidence that CryoPort now uses the same auditors that PTSC uses....

Carlton M. Johnson

Director

Peregrine Pharmaceuticals, Inc.

Tustin , CA

Sector: HEALTHCARE / Biotechnology

Director and Secretary , CryoPort, Incorporated

Lake Forest , CA

Sector: CONSUMER GOODS / Packaging & Containers

Officer since May 2009

Director , Ecotality Inc

Scottsdale , AZ

Sector: UTILITIES / Electric Utilities

Director , Patriot Scientific Corporation

San Diego , CA

Sector: TECHNOLOGY / Communication Equipm

Lake Forest , Calif. (October 13, 2009) - CryoPort, Inc. (OTCBB:CYRX) today announced that at its Annual Meeting of Shareholders held on October 9th, all corporate resolutions passed, except the authorization to issue preferred stock.

Resolutions for the election of all the members of the Board of Directors, the selection of KMJ Corbin & Company as the Company's auditor, approval of an increase to the number of common shares authorized and the ability of the Board of Directors to initiate a possible reverse split of the Company's outstanding common stock all passed. The proposal to authorize the creation of 25,000,000 shares of preferred stock did not pass because it did not obtain the affirmative vote of majority of the Company's outstanding shares of common stock.

Larry Stambaugh, CEO of CryoPort, stated, "I'm very pleased that our shareholders have supported management's recommendation on the resolutions. Having the flexibility to manage the capital structure of the Company will be important as we initiate the process of seeking to move from the OTC Bulletin Board to The NASDAQ Stock Market. Also, in connection with the recent filing of our Registration Statement on Form S-1 directed at raising $10 million of new capital, it is important for us to have these measures passed and in place to allow us to execute our commercialization strategies for the CryoPort Express®.

LAKE FOREST, CA--(Marketwire - February 4, 2010) - CryoPort, Inc. (OTCBB: CYRX) today announced that a previously approved reverse stock split of its outstanding common stock will take effect at the start of trading on the OTC Bulletin Board on Friday, February 5, 2010 on a 1-for-10 split-adjusted basis. CryoPort's shares will continue to trade on a split-adjusted basis under the temporary ticker symbol "CYRXD" for a period of 20 trading days to indicate the reverse stock split has occurred. CryoPort's symbol will revert back to its original symbol "CYRX" on March 8, 2010. In connection with the reverse split CryoPort's common stock has been assigned a new CUSIP number 229050 208.

The primary objective of the reverse stock split is to gain compliance with NASDAQ's minimum listing requirement in connection with the Company's planned stock offering in February and application to list its common stock on the NASDAQ Capital Market.

Under the terms of the reverse split, stockholders holding 10 shares or more of CryoPort common stock at the close of business on February 4, 2010 will receive one new CryoPort share for every 10 shares held. Stockholders who would otherwise have a fractional share as a result of the reverse stock split will receive cash consideration in lieu of such fractional share. The reverse split will reduce the number of shares of outstanding common stock from approximately 50.5 million, based on the number of shares outstanding as of January 27, 2010, to approximately 5.05 million. It also affects shares of common stock underlying stock options, warrants and convertible debt that are outstanding immediately prior to the effective date of the reverse stock split.

CryoPort also announced that it has appointed Continental Stock Transfer & Trust Company to serve as its transfer agent. Stockholders will be sent instructions for exchanging their existing stock certificates for new stock certificates, and for receiving cash compensation in lieu of fractional shares.